Theophylline: new perspectives for an old drug.

[1]  I. Adcock,et al.  Expression and activity of histone deacetylases in human asthmatic airways. , 2002, American journal of respiratory and critical care medicine.

[2]  I. Adcock,et al.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Dahl,et al.  Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms. , 2002, Respiratory medicine.

[4]  P. Barnes,et al.  Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[5]  S. Hasegawa,et al.  Theophylline inhibits NF-κB activation and IκBα degradation in human pulmonary epithelial cells , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[6]  I. Adcock,et al.  Low‐dose theophylline does not exert its anti‐inflammatory effects in mild asthma through upregulation of interleukin‐10 in alveolar macrophages , 2001, Allergy.

[7]  P. Diot,et al.  Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis. , 2001, The European respiratory journal.

[8]  I. Adcock,et al.  Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. , 2001, American journal of respiratory and critical care medicine.

[9]  C. Ezeamuzie.  Involvement of A(3) receptors in the potentiation by adenosine of the inhibitory effect of theophylline on human eosinophil degranulation: possible novel mechanism of the anti-inflammatory action of theophylline. , 2001, Biochemical pharmacology.

[10]  R. Zuwallack,et al.  Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.

[11]  A. Wolffe,et al.  Chromatin remodeling and transcriptional activation: the cast (in order of appearance) , 2001, Oncogene.

[12]  P. J. Barnes,et al.  IL‐10: a key regulator of allergic disease , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[14]  I. Adcock,et al.  Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  K. Chung,et al.  Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice , 2000, Thorax.

[16]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[17]  Y. H. Kim,et al.  The downregulation of Bcl-2 expression is necessary for theophylline-induced apoptosis of eosinophil. , 2000, Cellular immunology.

[18]  K. Shinozaki,et al.  Theophylline induces neutrophil apoptosis through adenosine A2A receptor antagonism , 2000, Journal of leukocyte biology.

[19]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[20]  K. Ohta,et al.  Apoptosis of eosinophils and lymphocytes in allergic inflammation. , 1999, The Journal of allergy and clinical immunology.

[21]  H. Chikumi,et al.  Functional assay of NF-κB translocation into nuclei by laser scanning cytometry: inhibitory effect by dexamethasone or theophylline , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  D. Faulds,et al.  Theophylline. A review of its potential steroid sparing effects in asthma. , 1998, Drugs.

[23]  I. Adcock,et al.  Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. , 1998, American journal of respiratory and critical care medicine.

[24]  S. Holgate,et al.  Adenosine A2B receptors: a novel therapeutic target in asthma? , 1998, Trends in pharmacological sciences.

[25]  K. Offord,et al.  Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. , 1998, The Journal of allergy and clinical immunology.

[26]  R. Sakalauskas,et al.  Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. , 1997, The European respiratory journal.

[27]  K. Chung,et al.  A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. , 1997, The New England journal of medicine.

[28]  A. Komiyama,et al.  Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. , 1997, The Journal of clinical investigation.

[29]  P. Barnes,et al.  Current therapies for asthma. Promise and limitations. , 1997, Chest.

[30]  J. Negri,et al.  Anti-inflammatory effects of theophylline: modulation of cytokine production. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  S. Wenzel,et al.  Theophylline: potential antiinflammatory effects in nocturnal asthma. , 1996, The Journal of allergy and clinical immunology.

[32]  C. Page,et al.  Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. , 1996, The European respiratory journal.

[33]  L. Kaminsky,et al.  Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. , 1995, Biochemical pharmacology.

[34]  K. Chung,et al.  Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. , 1995, American journal of respiratory and critical care medicine.

[35]  H. Magnussen,et al.  Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. , 1995, The European respiratory journal.

[36]  L. Boulet,et al.  Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. , 1995, American journal of respiratory and critical care medicine.

[37]  C. Page,et al.  Anti-inflammatory effects of low-dose oral theophylline in atopic asthma , 1994, The Lancet.

[38]  R. Pauwels,et al.  Theophylline in the management of asthma: time for reappraisal? , 1994, The European respiratory journal.

[39]  H. Magnussen,et al.  Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. , 1993, Chest.

[40]  K. Offord,et al.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. , 1993, Pediatrics.

[41]  C. Page,et al.  Theophylline--an immunomodulatory role in asthma? , 1993, The American review of respiratory disease.

[42]  M. Yacoub,et al.  Role of potassium channels in bronchodilator responses in human airways. , 1992, The American review of respiratory disease.

[43]  S. Dahlén,et al.  Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. , 1992, The American review of respiratory disease.

[44]  M. Newhouse,et al.  Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? , 1990, Chest.

[45]  R. Howell,et al.  Mechanism for the emetic side effect of xanthine bronchodilators. , 1990, Life sciences.

[46]  H. Chrystyn,et al.  Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.

[47]  J. Moxham.  Aminophylline and the respiratory muscles: an alternative view. , 1988, Clinics in chest medicine.

[48]  B. Littenberg.  Aminophylline treatment in severe, acute asthma. A meta-analysis. , 1988, JAMA.

[49]  R. Strunk,et al.  Need for theophylline in severe steroid‐requiring asthmatics , 1988, Clinical allergy.

[50]  L. Fabbri,et al.  Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects. , 1987, The American review of respiratory disease.

[51]  A. Wanner.  Effects of methylxanthines on airway mucociliary function. , 1985, The American journal of medicine.

[52]  R. Pauwels,et al.  The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. , 1985, The Journal of allergy and clinical immunology.

[53]  J. Karlsson,et al.  Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation , 1985, British journal of pharmacology.

[54]  S. Holgate,et al.  Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. , 1985, Thorax.

[55]  M. Badier,et al.  Spontaneous and provoked resistance to isoproterenol in isolated human bronchi. , 1984, The Journal of allergy and clinical immunology.

[56]  S. Holgate,et al.  Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. , 1984, The American review of respiratory disease.

[57]  P. Macklem,et al.  Aminophylline improves diaphragmatic contractility. , 1981, The New England journal of medicine.

[58]  A. L. Goldman,et al.  INHIBITION OF HUMAN PULMONARY PHOSPHODIESTERASE ACTIVITY BY THERAPEUTIC LEVELS OF THEOPHYLLINE , 1978, Clinical and experimental pharmacology & physiology.